SAVR + CABG | TAVR + OP/MIDCAB | TAVR + PCI | p-value (across groups) | |
---|---|---|---|---|
(n = 464) | (n = 50) | (n = 112) | ||
mean ± SD or median (IQR) or n (%) | mean ± SD or median (IQR) or n (%) | mean ± SD or median (IQR) or n (%) | ||
Access route | < 0.001 | |||
Transfemoral | n.a. | 0 (0.0) | 41 (36.6) | |
Transapical | n.a. | 29 (58.0) | 70 (62.5) | |
Transaortic | n.a. | 21 (42.0) | 1 (0.9) | |
Prosthesis diameter (mm) | 23.7 ± 2.3 | 26.1 ± 2.1 | 25.8 ± 2.1 | < 0.001 |
23 (23–25) | 26 (26–29) | 26 (23–27) | ||
Total intervention time (min) | 221 (190–245) | 175 (146–231) | 67 (53–83) | < 0.001 |
Total length of hospital stay (d) | 12.0 (9.0–17.0) | 11.0 (7.0–20.0) | 10.0 (7.0–15.0) | 0.011 |
Length of ICU stay (d) | 1.0 (1.0–4.0) | 1.0 (1.0–4.0) | 1.0 (1.0–1.0) | 0.001 |
Erythrocyte packs/patient | 2.7 ± 3.9 | 3.6 ± 4.29 | 1.7 ± 2.9 | 0.001 |